Fig. 1From: Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)Resolution of multi-focal (left frontal and right temporal lobe) disease in a 65 year old patient (ID No. 6) a) before and b) after two cycles of R-BOAD at interim analysisBack to article page
